blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2691376

EP2691376 - FE(III) COMPLEXES FOR THE TREATMENT AND PROPHYLAXIS OF IRON DEFICIENCY SYMPTOMS AND IRON DEFICIENCY ANAEMIAS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.10.2016
Database last updated on 23.04.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Vifor (International) AG
Rechenstraße 37
9001 St. Gallen / CH
[2014/06]
Inventor(s)01 / BARK, Thomas
Viktoriastrasse 55
8050 Zürich / CH
02 / BUHR, Wilm
Zum Kirchwald 20
78465 Konstanz / DE
03 / BURCKHARDT, Susanna
Ackersteinstrasse 207
8049 Zürich / CH
04 / BURGERT, Michael
Appenzellerstrasse 25
88045 Friedrichshafen / DE
05 / CANCLINI, Camillo
Fichstestrasse 15
9000 St. Gallen / CH
06 / DÜRRENBERGER, Franz
Dorneckstrasse 127
4143 Dornach / CH
07 / FUNK, Felix
Römerstrasse 177b
8404 Winterthur / CH
08 / GEISSER, Peter Otto
Marweesstrasse 8
9014 St. Gallen / CH
09 / KALOGERAKIS, Aris
Kurzstrasse 1
8400 Winterthur / CH
10 / MAYER, Simona
Egg 643
9055 Bühler / CH
11 / PHILIPP, Erik
Schwalbenstrasse 1
9320 Arbon / CH
12 / REIM, Stefan
Grundhofstrasse 68
8404 Winterthur / CH
13 / SIEBER, Diana
Rossweidstrasse 3a
9030 Abtwil / CH
14 / SCHMITT, Jörg
Heidlerstrasse 7
9425 Thal / CH
15 / SCHWARZ, Katrin
Ringelbergstrasse 4
9000 St. Gallen / CH
 [2014/06]
Representative(s)Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte
Brucknerstraße 20
40593 Düsseldorf / DE
[N/P]
Former [2015/50]Gille Hrabal
Brucknerstrasse 20
40593 Düsseldorf / DE
Former [2014/06]Gille Hrabal
Patentanwälte
Brucknerstrasse 20
40593 Düsseldorf / DE
Application number, filing date12711629.128.03.2012
[2015/50]
WO2012EP55512
Priority number, dateEP2011016015129.03.2011         Original published format: EP 11160151
[2014/06]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2012130882
Date:04.10.2012
Language:DE
[2012/40]
Type: A1 Application with search report 
No.:EP2691376
Date:05.02.2014
Language:DE
The application published by WIPO in one of the EPO official languages on 04.10.2012 takes the place of the publication of the European patent application.
[2014/06]
Type: B1 Patent specification 
No.:EP2691376
Date:09.12.2015
Language:DE
[2015/50]
Search report(s)International search report - published on:EP04.10.2012
ClassificationIPC:C07D239/34, C07D239/80, A61P7/00, A61K31/26, A61K33/26, A61K31/513
[2015/28]
CPC:
C07D239/34 (EP,US); C07F15/02 (KR); A61K31/295 (KR);
A61K31/513 (EP,US); A61K31/555 (EP,US); A61K33/26 (EP,US);
A61K45/06 (US); A61P3/02 (EP); A61P7/00 (EP);
A61P7/06 (EP); C07D239/46 (EP,US); C07D239/47 (EP,US);
C07D239/70 (EP,US); C07D239/80 (EP,US) (-)
C-Set:
A61K31/513, A61K2300/00 (US,EP);
A61K33/26, A61K2300/00 (EP,US)
Former IPC [2014/06]C07D239/34, C07D239/80, A61P7/00, A61K31/26
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/06]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:FE(III)-KOMPLEXVERBINDUNGEN ZUR BEHANDLUNG UND PROPHYLAXE VON EISENMANGELERSCHEINUNGEN UND EISENMANGELANÄMIEN[2014/06]
English:FE(III) COMPLEXES FOR THE TREATMENT AND PROPHYLAXIS OF IRON DEFICIENCY SYMPTOMS AND IRON DEFICIENCY ANAEMIAS[2014/06]
French:COMPOSÉS À BASE DE COMPLEXES DE FE(III) POUR LE TRAITEMENT ET LA PRÉVENTION DE CARENCES EN FER ET D'ANÉMIES DUES À UNE CARENCE EN FER[2014/06]
Entry into regional phase18.10.2013National basic fee paid 
18.10.2013Designation fee(s) paid 
18.10.2013Examination fee paid 
Examination procedure18.10.2013Examination requested  [2014/06]
11.04.2014Amendment by applicant (claims and/or description)
10.12.2014Despatch of a communication from the examining division (Time limit: M02)
04.02.2015Reply to a communication from the examining division
20.07.2015Communication of intention to grant the patent
25.09.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
25.09.2015Fee for grant paid
25.09.2015Fee for publishing/printing paid
20.10.2015Information about intention to grant a patent
20.10.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.12.2014
Opposition(s)12.09.2016No opposition filed within time limit [2016/46]
Fees paidRenewal fee
26.03.2014Renewal fee patent year 03
20.03.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL09.12.2015
BG09.12.2015
CY09.12.2015
EE09.12.2015
HR09.12.2015
LT09.12.2015
LV09.12.2015
MC09.12.2015
MK09.12.2015
MT09.12.2015
RS09.12.2015
SI09.12.2015
SK09.12.2015
SM09.12.2015
IS09.04.2016
[2018/46]
Former [2018/38]BG09.12.2015
CY09.12.2015
EE09.12.2015
HR09.12.2015
LT09.12.2015
LV09.12.2015
MC09.12.2015
MK09.12.2015
MT09.12.2015
RS09.12.2015
SI09.12.2015
SK09.12.2015
SM09.12.2015
IS09.04.2016
Former [2018/29]CY09.12.2015
EE09.12.2015
HR09.12.2015
LT09.12.2015
LV09.12.2015
MC09.12.2015
MK09.12.2015
MT09.12.2015
RS09.12.2015
SI09.12.2015
SK09.12.2015
SM09.12.2015
IS09.04.2016
Former [2017/47]EE09.12.2015
LT09.12.2015
LV09.12.2015
MC09.12.2015
MT09.12.2015
RS09.12.2015
SI09.12.2015
SK09.12.2015
SM09.12.2015
IS09.04.2016
Former [2016/49]EE09.12.2015
LT09.12.2015
LV09.12.2015
MC09.12.2015
RS09.12.2015
SI09.12.2015
SK09.12.2015
SM09.12.2015
IS09.04.2016
Former [2016/38]EE09.12.2015
LT09.12.2015
LV09.12.2015
RS09.12.2015
SK09.12.2015
SM09.12.2015
IS09.04.2016
Former [2016/36]EE09.12.2015
IS09.12.2015
LT09.12.2015
LV09.12.2015
RS09.12.2015
SK09.12.2015
Former [2016/31]IS09.12.2015
LT09.12.2015
LV09.12.2015
RS09.12.2015
Former [2016/25]LT09.12.2015
LV09.12.2015
RS09.12.2015
Former [2016/23]LT09.12.2015
RS09.12.2015
Former [2016/20]LT09.12.2015
Cited inInternational search[AD]EP0138420  (NAT RES DEV [GB]) [AD] 1-18* abstract *;
 [XA]  - J OHKANDA ET AL, "N-Hydroxyamide-Containing Heterocycles. Part 2. Synthesis and Iron(III) Complex-Forming Tendency of 1-Hydroxy-2(1H)-pyrimidinone and -pyrazinone", BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, (19930101), vol. 66, pages 841 - 847, XP055000884 [X] 9 * figure 3 * * table 3 * * page 846, column 2, paragraph 5 * * page 841, column 1, paragraph 1 * [A] 1-8,10-18

DOI:   http://dx.doi.org/10.1246/bcsj.66.841
by applicantUS474670
 GB842637
 EP0107458
 EP0138420
 EP0150085
 EP0159194
 EP0308362
 JPH0283400
 ES2044777
 EP0939083
 US2003236224
 WO2004043786
 CN1687089
 WO2006037449
 WO2007062546
 WO2008145558
 US2009035385
 CN101481404
    - M.W. HENTZE, "Balancing acts: molecular control of mammalian iron metabolism", CELL, (2004), vol. 117, pages 285 - 297
    - BIOMETALS, (2009), vol. 22, pages 701 - 710
    - BULL. CHEM. SOC. JPN., page 66
    - REVIEWS ON HETEROATOM CHEMISTRY, (1998), vol. 18, pages 87 - 118
    - J. ORG. CHEM., (1997), vol. 62, pages 3618 - 3624
    - J. AM. CHEM. SOC., (1985), vol. 107, pages 6540 - 6546
    - INORGANICA CHIMICA ACTA, (1987), vol. 135, pages 145 - 150
    - TETRAHEDRON, (1967), vol. 23, pages 353 - 357
    - OHKANDA, BULL. CHEM. SOC. JPN., (1993), vol. 66, page 841
    - CAN. J. CHEM., (1984), vol. 62, pages 1176 - 1180
    - E.E. ROYALS; K.C. BRANNOCK, J. AM. CHEM. SOC., (1953), vol. 75, pages 2050 - 2053
    - E.E.; K.C. BRANNOCK, J. AM. CHEM. SOC., (1953), vol. 75, pages 2050 - 2053
    - M. YAMAGUCHI ET AL., J. LNORG. BIOCHEMISTRY, (2006), vol. 100, pages 260 - 269
    - E.E. ROYALS; K.C. BRANNOCK, J. . CHEM. SOC., (1953), vol. 75, pages 2050 - 2053
    - M. YAMAGUCHI ET AL., J. INORG. BIOCHEMISTRY, (2006), vol. 100, pages 260 - 269
    - YAMAGUCHI ET AL., J. LNORG. BIOCHEMISTRY, (2006), page 100
    - YAMAGUCHI ET AL., J. LNORG. BIOCHEMISTRY, (2006), vol. 100, pages 260 - 269
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.